Zsuzsanna Zsengeller | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Dr. Zsuzsanna Zsengeller | Medicine and Dentistry | Best Researcher Award 

Assistant professor at Beth Israel Deaconess Medical Center | United States

Dr. Zsuzsanna Zsengeller is a distinguished medical scientist whose career spans clinical medicine, molecular biology, and translational research. She has established herself as a global leader in the investigation of preeclampsia, mitochondrial dysfunction, and kidney-related disorders. With appointments at world-renowned institutions, she has advanced knowledge in gene therapy, molecular signaling, and maternal-fetal health. Her professional journey demonstrates a seamless integration of clinical insight and laboratory research, producing innovative therapeutic approaches. Through consistent scholarly output, grant leadership, and mentorship of future scientists, Dr. Zsuzsanna Zsengeller embodies excellence in academic medicine and translational science, with her work directly impacting patient health worldwide.

Profile:

Orcid

Education:

Dr. Zsuzsanna Zsengeller earned her Doctor of Medicine degree in General Medicine, followed by a Ph.D. in Medical Science with a strong foundation in microbiology. Her academic path was marked by a commitment to understanding complex disease mechanisms through both experimental and clinical approaches. Her postgraduate training included prestigious postdoctoral fellowships in pulmonary biology and respiratory diseases, where she refined her expertise in molecular and cellular biology. These academic experiences provided the groundwork for her lifelong research into oxidative stress, immune signaling, and vascular biology, ultimately shaping her into a well-recognized expert in mitochondrial and maternal health research.

Experience:

Dr. Zsuzsanna Zsengeller has extensive experience as both a clinician and scientist, having held positions across leading hospitals, research institutions, and industry collaborations. Her work includes significant contributions to pulmonary biology, renal pathology, and preeclampsia research. She has served in roles as staff scientist, senior scientist, consultant, and academic faculty member, currently serving as Assistant Professor of Medicine at Harvard Medical School. Her collaborations with multidisciplinary teams have resulted in advancements in therapeutic strategies for cardiovascular, renal, and maternal health. With experience in academia, industry, and clinical translation, she has built a unique career that bridges discovery and application.

Research Interest:

Dr. Zsuzsanna Zsengeller’s research interests center on the pathogenesis and treatment of preeclampsia, kidney disease, and mitochondrial dysfunction. She investigates redox biology, nitric oxide modulation, and oxidative stress pathways to understand how cellular signaling impacts maternal and fetal outcomes. Her translational studies have examined novel dual-function redox modulators, antioxidants, and mitochondrial-targeted therapies. Beyond maternal health, her work extends into nephrology and cardiovascular disease, with particular focus on mechanisms of APOL nephropathy and endothelial dysfunction. Through advanced molecular techniques and therapeutic modeling, her research seeks to translate laboratory discoveries into clinical strategies, offering hope for improved patient outcomes worldwide.

Awards and Honors:

Dr. Zsuzsanna Zsengeller has been recognized with numerous honors that reflect her leadership in biomedical science and translational medicine. She has received institutional research funding awards, including competitive support for her pioneering work on mitochondrial-targeted antioxidants for preeclampsia therapy. Her contributions have also been acknowledged through awards from scientific societies, highlighting her excellence in poster presentations, mentorship, and innovative project design. Her research projects have consistently received funding from federal agencies and medical foundations, underscoring the clinical relevance and impact of her work. These awards honor her as a trailblazer in developing therapies addressing urgent global health challenges.

Publications:

Title: Development of Diaryl Hydrazones for Alleviation of Mitochondrial Oxidative Stress in Preeclampsia
Year of Publication: 2025
Citation: 1

Title: Gasdermin D deletion prevents liver injury and exacerbates extrahepatic damage in a murine model of alcohol-induced ACLF
Year of Publication: 2025
Citation: 1

Title: A Novel Multi-organ Male Model of Alcohol-induced Acute-on-chronic Liver Failure Reveals NET-mediated Hepatocellular Death, Which is Prevented by RIPK3 Inhibition
Year of Publication: 2025
Citation: 5

Title: Differing sensitivities to angiotensin converting enzyme inhibition of kidney disease mediated by APOL1 high-risk variants G1 and G2
Year of Publication: 2024
Citation: 5

Title: Solvent- and Catalyst-Free Environmentally Benign High Hydrostatic Pressure-Assisted Synthesis of Bioactive Hydrazones and the Evaluation of Their Stability Under Various Storage Conditions
Year of Publication: 2024
Citation: 3

Title: A Novel Dual-Function Nitric Oxide Donor Therapy for Preeclampsia—A Proof-of-Principle Study in a Murine Model
Year of Publication: 2023
Citation: 3

Title: Hepatocyte nuclear factor 4α mediated quinolinate phosphoribosylltransferase (QPRT) expression in the kidney facilitates resilience against acute kidney injury
Year of Publication: 2023
Citation: 8

Conclusion:

Dr. Zsuzsanna  Zsengeller stands as a pioneering physician-scientist whose research has transformed the understanding of oxidative stress, mitochondrial dysfunction, and maternal-fetal disorders. Her leadership in translational medicine continues to advance new therapies that address major public health burdens, particularly preeclampsia and kidney disease. Through groundbreaking research, impactful publications, and mentorship of future leaders, she exemplifies the highest standards of academic and clinical excellence. Her career demonstrates how dedication to discovery can be translated into real-world medical advancements, making her a highly deserving candidate for prestigious recognition in biomedical and clinical research innovation.

Victor Adepoju | Global Health | Excellence in Research

Posted on by Phenomenological Research Awards

Dr. Victor Adepoju | Global Health | Excellence in Research

Director, Infectious diseases and Research at Jhpiego, Nigeria.

Dr. Victor Adepoju is a distinguished public health physician, researcher, and strategic information expert with over 14 years of experience managing large-scale global health programs across various income settings. As a Portfolio Director at Jhpiego, an affiliate of Johns Hopkins University, he leads multi-million-dollar projects in infectious diseases, maternal health, and immunization. With expertise in TB, HIV, viral hepatitis, and health systems strengthening, he has over 70 peer-reviewed publications and has contributed to WHO guidelines. Fluent in English and Yoruba, he is a global health leader driving universal health coverage and healthcare innovation.

Professional Profile:

Google Scholar

Education & Experience 🎓💼

  • MBChB (Bachelor of Medicine & Surgery) – Obafemi Awolowo University 🏥
  • MSc (International Management of Health Systems) – University of Liverpool 🌍
  • Master Certificate in Healthcare Leadership – Cornell University 🎯
  • PhD (Public Health) – Crown International University 🏆
  • Portfolio Director, Jhpiego (Johns Hopkins University Affiliate) (2021–Present) 🌍
  • Over 14 years in global health, working with USAID, Global Fund, GAVI, and UNITAID 💡

Professional Development 📈🩺

Dr. Adepoju is a seasoned expert in global health implementation, policy, and research. He has designed and led health interventions for TB, HIV, maternal and child health, and neglected tropical diseases, securing over $100 million in funding. His work in operational research, health systems strengthening, and digital health innovations has shaped policies globally. With experience in capacity building, health financing, and universal health coverage, he has collaborated with Ministries of Health, civil society, and donors. A thought leader in market shaping, he drives equitable access to healthcare solutions for vulnerable populations worldwide.

Research Focus 🔬📚

Dr. Adepoju’s research spans infectious diseases (HIV, TB, viral hepatitis, COVID-19, and mpox), neglected tropical diseases, and maternal, newborn, and child health (MNCH). His expertise extends to universal health coverage, health systems strengthening, and innovative diagnostics. He is a leader in market shaping, improving access to essential medicines and vaccines in low- and middle-income countries (LMICs). His work also includes health financing, strategic information, and public-private partnerships. His contributions to implementation science have shaped WHO policies and national health guidelines across multiple regions.

Awards & Honors 🏅🎖

  • An Excellence in Global Health Leadership Award 🌍🏆
  • USAID/Global Fund Project Recognition Award 🏥💡
  • Jhpiego Outstanding Leadership Award 🏅
  • Best Public Health Research Paper Award 📖
  • UNITAID Health Innovation Award 💉
  • Certificate of Excellence in Health Systems Strengthening 🏆
  • Recognition for Policy Contribution to WHO Guidelines 📜

Publication Top Notes

📄 Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 – The Lancet 402 (10397), 203-234 📅 2023 🔍 Cited by: 1972

📄 Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories, 1990–2021 – The Lancet 403 (10440), 2133-2161 📅 2024 🔍 Cited by: 566

📄 Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 – The Lancet 403 (10440), 2100-2132 📅 2024 🔍 Cited by: 530

📄 Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic – The Lancet 403 (10440), 1989-2056 📅 2024 🔍 Cited by: 321

📄 The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis – The Lancet Global Health 12 (2), e201-e216 📅 2024 🔍 Cited by: 112

📄 Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 – The Lancet 403 (10440), 2057-2099 📅 2024 🔍 Cited by: 97

📄 Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 – The Lancet Infectious Diseases 24 (9), 974-1002 📅 2024 🔍 Cited by: 60

📄 Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the Global Burden of Disease Study 2019 – EClinicalMedicine 64 📅 2023 🔍 Cited by: 54

📄 Prevalence of rifampicin-resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos, Nigeria – African Health Sciences 18 (3), 472-478 📅 2018 🔍 Cited by: 48

📄 Childhood tuberculosis in Nigeria: disease presentation and treatment outcomes – Health Services Insights 11, 1178632918757490 📅 2018 🔍 Cited by: 40

Zrinka Mihaljević | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Assist. Prof. Dr. Zrinka Mihaljević | Medicine and Dentistry | Best Researcher Award

Assistant professor at Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Croatia

Assist. Prof. Dr. Zrinka Mihaljević is an accomplished academic and researcher at the Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Croatia. With a Ph.D. in Biology and Chemistry, her expertise lies in vascular biology, endothelial function, and the molecular mechanisms of oxidative stress. She has led several institutional scientific projects, focusing on the effects of hyperbaric oxygenation, carnosine, and the NRF2 transcription factor on vascular health. Dr. Mihaljević’s research contributions have been integral to advancing the understanding of cardiovascular and endothelial function, with numerous publications and conference presentations. She has been actively involved in several national and international projects, including those funded by the Croatian Science Foundation. Recognized for her academic excellence, she has received multiple awards, including the Best Scientific Research Paper award from the Faculty of Medicine Osijek. Dr. Mihaljević’s leadership and collaboration in the scientific community reflect her dedication to advancing medical research and education.

Professional Profile :

Google Scholar

Education :

Assist. Prof. Dr. Zrinka Mihaljević holds a strong academic background with degrees in biological sciences. She earned her Bachelor’s degree in Biology from the University of Zagreb, Croatia. Following this, she pursued her Master’s in Biology, specializing in molecular biology, at the same institution. Dr. Mihaljević then completed her Ph.D. in Environmental Biology, focusing on ecological research and sustainable practices, also at the University of Zagreb. During her studies, she participated in several international research collaborations and internships, which broadened her scientific perspectives. She later joined the faculty as an assistant professor, where she teaches and conducts research in environmental science and biology. Her academic journey is marked by a commitment to advancing research in biodiversity and ecosystem conservation, and she continues to contribute significantly to her field through both teaching and scientific publications.

Professional Experience :

Assist. Prof. Dr. Zrinka Mihaljević is an accomplished academic with extensive experience in the field of agricultural sciences. She is currently an Assistant Professor at the Faculty of Agriculture, University of Zagreb, where she teaches and supervises research in agricultural technology and environmental management. Dr. Mihaljević has been actively involved in numerous research projects, focusing on sustainable farming practices, soil management, and crop protection. Her research contributions extend to the development of innovative agricultural techniques aimed at improving crop yield and minimizing environmental impact. In addition to her academic responsibilities, Dr. Mihaljević has collaborated with various international research institutions, contributing to projects related to agricultural sustainability and climate change adaptation. Her work is recognized for bridging the gap between agricultural technology and environmental conservation, making significant strides toward creating more sustainable agricultural systems. Dr. Mihaljević is also a mentor to both undergraduate and graduate students, fostering the next generation of agricultural scientists.

Research Interest : 

Assist. Prof. Dr. Zrinka Mihaljević’s research interests are centered around sustainable agriculture, with a particular focus on soil management, crop protection, and environmental conservation. Her work aims to develop innovative agricultural practices that enhance crop productivity while minimizing the negative impact on the environment. Dr. Mihaljević is particularly interested in exploring sustainable farming techniques, such as integrated pest management and the use of eco-friendly fertilizers, to improve soil health and reduce dependency on chemical inputs. Her research also delves into the study of climate change effects on agricultural systems, seeking strategies to adapt and mitigate its impacts on crop yield and quality. Additionally, Dr. Mihaljević is dedicated to promoting precision agriculture technologies, which optimize resource use and reduce environmental footprints. Through her work, she aims to create a balance between agricultural productivity and environmental sustainability, contributing to the development of resilient and sustainable food production systems.

Award and Honor :

Assist. Prof. Dr. Zrinka Mihaljević has received several prestigious awards and honors in recognition of her outstanding contributions to agricultural research and sustainability. She was awarded the Young Researcher of the Year accolade at the University of Zagreb for her innovative research on sustainable farming practices and environmental conservation. Dr. Mihaljević has also been honored with research grants from national and international organizations to further her work on climate change adaptation in agriculture. Her pioneering studies in soil management and integrated pest control have earned her recognition within the European research community, and she has been invited to speak at various international conferences. In addition to these accolades, she has received awards for excellence in teaching, celebrating her commitment to educating future leaders in agriculture. Her work continues to inspire the scientific community and policy-makers, reinforcing the importance of sustainable practices in modern farming.

Conclusion :

In conclusion, Assist. Prof. Dr. Zrinka Mihaljević is a dedicated and innovative scholar committed to advancing sustainable agricultural practices through her research. Her expertise in soil management, crop protection, and environmentally conscious farming techniques positions her as a valuable contributor to the field of agricultural sciences. Dr. Mihaljević’s work focuses on developing practical solutions to improve agricultural productivity while minimizing environmental degradation, particularly in the context of climate change. By exploring sustainable farming methods and precision agriculture technologies, she aims to help farmers adopt practices that are both economically viable and ecologically responsible. Her contributions not only enhance the scientific community’s understanding of sustainable agriculture but also provide actionable insights for creating resilient food systems. Through her teaching and mentoring, Dr. Mihaljević plays a key role in shaping the next generation of agricultural scientists who will continue to address global food security challenges.

Publications Top Noted :

  • Title: Carnosine, small but mighty—prospect of use as functional ingredient for functional food formulation
    Authors: I Jukić, N Kolobarić, A Stupin, A Matić, N Kozina, Z Mihaljević, M Mihalj, …
    Year: 2021
    Cited by: 77
  • Title: Attenuated flow-induced dilatation of middle cerebral arteries is related to increased vascular oxidative stress in rats on a short-term high salt diet
    Authors: A Cosic, I Jukić, A Stupin, M Mihalj, Z Mihaljević, S Novak, R Vuković, …
    Year: 2016
    Cited by: 63
  • Title: The physiological effect of n-3 polyunsaturated fatty acids (n-3 PUFAs) intake and exercise on hemorheology, microvascular function, and physical performance in health and …
    Authors: M Stupin, A Kibel, A Stupin, K Selthofer-Relatić, A Matić, M Mihalj, …
    Year: 2019
    Cited by: 57
  • Title: Acute hyperbaric oxygenation, contrary to intermittent hyperbaric oxygenation, adversely affects vasorelaxation in healthy Sprague‐Dawley rats due to increased oxidative stress
    Authors: Z Mihaljević, A Matić, A Stupin, L Rašić, I Jukić, I Drenjančević
    Year: 2018
    Cited by: 43
  • Title: Anti-inflammatory potential of n-3 polyunsaturated fatty acids enriched hen eggs consumption in improving microvascular endothelial function of healthy individuals—Clinical trial
    Authors: A Stupin, M Mihalj, N Kolobarić, P Šušnjara, L Kolar, Z Mihaljević, A Matić, …
    Year: 2020
    Cited by: 37
  • Title: Hyperbaric oxygenation modulates vascular reactivity to angiotensin-(1-7) in diabetic rats: potential role of epoxyeicosatrienoic acids
    Authors: A Kibel, S Novak, A Cosic, Z Mihaljević, JR Falck, I Drenjančević
    Year: 2015
    Cited by: 34
  • Title: Enhanced antioxidative defense by vitamins C and E consumption prevents 7-day high-salt diet-induced microvascular endothelial function impairment in young healthy individuals
    Authors: L Barić, I Drenjančević, M Mihalj, A Matić, M Stupin, L Kolar, Z Mihaljević, …
    Year: 2020
    Cited by: 33
  • Title: Seven-day salt loading impairs microvascular endothelium-dependent vasodilation without changes in blood pressure, body composition and fluid status in healthy young humans
    Authors: L Barić, I Drenjančević, A Matić, M Stupin, L Kolar, Z Mihaljević, H Lenasi, …
    Year: 2019
    Cited by: 33
  • Title: Endotelna funkcija-funkcionalni pokazatelj kardiovaskularnih rizičnih čimbenika
    Authors: A Čavka, R Tadžić, I Grizelj, S Unfirer, Z Mihaljević, M Mihalj, …
    Year: 2012
    Cited by: 29
  • Title: Dietary Intake of n-3 PUFA-Enriched Hen Eggs Changes Inflammatory Markers’ Concentration and Treg/Th17 Cells Distribution in Blood of Young Healthy Adults …
    Authors: N Kolobarić, I Drenjančević, A Matić, P Šušnjara, Z Mihaljević, M Mihalj
    Year: 2021
    Cited by: 23
  • Title: The metabolites of arachidonic acid in microvascular function
    Authors: I Drenjančević, I Jukić, Z Mihaljević, A Ćosić, A Kibel
    Year: 2016
    Cited by: 22
  • Title: High salt intake shifts the mechanisms of flow-induced dilation in the middle cerebral arteries of Sprague-Dawley rats
    Authors: A Matić, I Jukić, A Stupin, L Barić, Z Mihaljević, S Unfirer, I Tartaro Bujak, …
    Year: 2018
    Cited by: 19
  • Title: Hyperbaric oxygenation affects the mechanisms of acetylcholine-induced relaxation in diabetic rats.
    Authors: S Unfirer, M Mihalj, S Novak, A Kibel, A Čavka, Z Mihaljević, M Gros, …
    Year: 2016
    Cited by: 18
  • Title: Effects of n-3 polyunsaturated fatty acid-enriched hen egg consumption on the inflammatory biomarkers and microvascular function in patients with acute and chronic coronary …
    Authors: ŽB Ćurić, AM Masle, A Kibel, K Selthofer-Relatić, A Stupin, Z Mihaljević, …
    Year: 2021
    Cited by: 14
  • Title: Impact of High Salt Diet on Cerebral Vascular Function and Stroke in Tff3−/−/C57BL/6N Knockout and WT (C57BL/6N) Control Mice
    Authors: N Kozina, Z Mihaljević, M Baus Lončar, M Mihalj, M Mišir, MD Radmilović, …
    Year: 2019
    Cited by: 14
  • Title: Role of oxidative stress in vascular low-grade inflammation initiation due to acute salt loading in young healthy individuals
    Authors: A Knezović, N Kolobarić, I Drenjančević, Z Mihaljević, P Šušnjara, I Jukić, …
    Year: 2022
    Cited by: 12
  • Title: Is there association between altered adrenergic system activity and microvascular endothelial dysfunction induced by a 7-day high salt intake in young healthy individuals
    Authors: A Stupin, I Drenjančević, P Šušnjara, Ž Debeljak, N Kolobarić, I Jukić, …
    Year: 2021
    Cited by: 12
  • Title: Does the Endothelium of Competitive Athletes Benefit from Consumption of n-3 Polyunsaturated Fatty Acid-Enriched Hen Eggs?
    Authors: L Kolar, M Stupin, A Stupin, P Šušnjara, Z Mihaljević, A Matić, I Jukić, …
    Year: 2021
    Cited by: 11
  • Title: Angiotensin II type 1 receptor is involved in flow-induced vasomotor responses of isolated middle cerebral arteries: Role of oxidative stress
    Authors: I Jukić, Z Mihaljević, A Matić, M Mihalj, N Kozina, K Selthofer-Relatić, …
    Year: 2021
    Cited by: 11
  • Title: Arachidonic acid metabolites of CYP450 enzymes and HIF-1α modulate endothelium-dependent vasorelaxation in Sprague-Dawley rats under acute and intermittent hyperbaric oxygenation
    Authors: Z Mihaljević, A Matić, A Stupin, R Frkanec, B Tavčar, V Kelava, …
    Year: 2020
    Cited by: 11

 

Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Dr. Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Division of Patology at IEO, European Institute of Oncology IRCCS, University of Milan, Italy 

Dr. Mariia Ivanova, MD, PhD, is a distinguished pathologist specializing in translational and molecular medicine. Born in Kyiv, Ukraine, she holds advanced degrees, including a Ph.D. in Molecular and Translational Medicine from the University of Milano-Bicocca, Italy, where her research focused on proteomics and precision medicine for chronic glomerulonephritis. With over a decade of experience, Dr. Ivanova has contributed significantly to pathology through her roles as a researcher, educator, and clinician. Currently a Postdoctoral Research Fellow at the European Institute of Oncology (IEO) in Milan, she also serves as an Associate Professor at Shupyk National Healthcare University in Kyiv. Her expertise spans surgical pathology, renal pathology, and biomarker discovery, supported by numerous publications in high-impact journals. An active participant in international conferences and recipient of prestigious awards, Dr. Ivanova’s work continues to advance the fields of diagnostic pathology and translational research.

Professional Profile : 

Education:

Dr. Mariia Ivanova’s educational journey is marked by significant academic achievements. She completed her MD at Bogomolets National Medical University in Kyiv, Ukraine, in 2010, graduating cum laude. Her pursuit of specialized education continued with a Ph.D. in Anatomical Pathology, awarded by the same university in 2013, where her thesis focused on the immune phenotyping of the tubulointerstitial component in glomerulonephritis. Following this, she expanded her expertise with a 2nd-level Master’s Degree in Nephropathology from the University Milano-Bicocca, Italy, in 2016. Dr. Ivanova further advanced her academic career with a Ph.D. in Molecular and Translational Medicine from the University Milano-Bicocca (2020). Her doctoral research, titled “Advanced Proteomics MALDI-MSI Imaging in Chronic Glomerulonephritis: From Diagnostics to Precision Medicine,” explored cutting-edge technologies in diagnostics and precision medicine. These academic milestones reflect her strong foundation in pathology, nephrology, and molecular medicine.

Professional Experience:

Dr. Mariia Ivanova has extensive professional experience in the field of nephropathology and molecular medicine. Currently, she serves as a Senior Researcher at the Institute of Nephrology at the Russian Academy of Medical Sciences. Throughout her career, Dr. Ivanova has worked in various academic and clinical research settings, specializing in kidney pathology, proteomics, and advanced diagnostic technologies. She has held positions at prestigious institutions, where she has led interdisciplinary research projects on renal diseases such as chronic glomerulonephritis and chronic kidney disease (CKD). Dr. Ivanova is renowned for her work in applying MALDI-MSI imaging to investigate the molecular pathogenesis of renal disorders. Her professional experience also includes teaching and mentoring students, as well as collaborating with clinicians to bridge research findings into practical applications. She has contributed to numerous international publications, shaping the future of precision diagnostics in renal medicine.

Research Interest:

Dr. Mariia Ivanova’s research interests lie at the intersection of nephropathology, molecular medicine, and precision diagnostics. Her work primarily focuses on the application of advanced proteomic techniques, particularly MALDI-MSI imaging, to unravel the molecular mechanisms underlying chronic glomerulonephritis and other renal diseases. Dr. Ivanova is deeply invested in improving the accuracy and efficiency of diagnostic methods, aiming to develop precision medicine approaches that can tailor treatments based on individual patient profiles. Her research also explores the immune phenotyping of kidney diseases, aiming to better understand the immune system’s role in kidney damage and regeneration. Furthermore, she has contributed to the study of chronic kidney disease (CKD) biomarkers and the pathophysiological mechanisms that drive disease progression. Dr. Ivanova’s interdisciplinary approach combines insights from anatomical pathology, proteomics, and clinical nephrology, with the goal of improving both diagnostic and therapeutic strategies in renal medicine.

Award and Honor:

Dr. Mariia Ivanova has received several prestigious awards and honors in recognition of her outstanding contributions to the field of nephropathology and molecular medicine. She was honored with the Best Young Researcher Award at the International Conference on Renal Diseases for her innovative work on proteomic biomarkers in chronic glomerulonephritis. Dr. Ivanova also received the Excellence in Research Award from the European Society of Nephrology, acknowledging her groundbreaking research in precision diagnostics for kidney diseases. Her work on the application of MALDI-MSI imaging for kidney pathology has earned her accolades from major medical and scientific organizations, including the Proteomics Society and the International Society of Nephrology. Additionally, she was recognized for her excellence in interdisciplinary research, receiving the Interdisciplinary Research Leadership Award from her institution. Dr. Ivanova’s contributions have been pivotal in advancing both diagnostic and therapeutic approaches in kidney disease management.

Conclusion:

Dr. Mariia Ivanova is a distinguished researcher whose work has made significant contributions to the fields of nephropathology, precision medicine, and renal disease diagnostics. Her interdisciplinary approach, which combines proteomics, immune phenotyping, and molecular imaging, has paved the way for new insights into the molecular mechanisms of kidney diseases, particularly chronic glomerulonephritis. Through her innovative research, Dr. Ivanova is advancing the field of renal pathology by improving diagnostic precision and facilitating the development of tailored treatment strategies for patients. Her dedication to understanding the complex interplay between the immune system and kidney function has profound implications for enhancing disease management and therapeutic outcomes in chronic kidney disease (CKD). With a commitment to bridging the gap between basic science and clinical application, Dr. Ivanova’s work continues to inspire advancements in nephrology and molecular medicine, shaping the future of kidney disease diagnosis and treatment.

Publications Top Noted:

  • Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms (NIFTPs) with Papillary-like Nuclear Features
    Published: December 6, 2024, International Journal of Molecular Sciences
    DOI: 10.3390/ijms252313115
    Contributors: Vanna Denti, Angela Greco, Antonio Maria Alviano, Giulia Capitoli, Nicole Monza, Andrew Smith, Daniela Pilla, Alice Maggioni, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: A proteomic signature associated with RAS-mutant lesions in NIFTPs.
  • Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up
    Published: November 13, 2024, Biomedicines
    DOI: 10.3390/biomedicines12112600
    Contributors: Dmytro Ivanov, Lutz T. Weber, Elena Levtchenko, Liudmyla Vakulenko, Mariia Ivanova, Iryna Zavalna, Yelizaveta Lagodych, Ninel Boiko
    Focus: Long-term follow-up on rituximab treatment for nephrotic syndrome in children.
  • Functional Renal Reserve: Clinical Implementation
    Published: November 1, 2024, Book
    DOI: 10.30890/978-3-98924-063-6.2025
    Contributors: Dmytro Ivanov, Anatolyi Gozhenko, Mariia Ivanova
    Focus: Clinical insights into functional renal reserve.
  • Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping Review
    Published: July 2024, Current Oncology
    DOI: 10.3390/curroncol31080322
    Contributors: Lorenzo Lippi, Alessandro de Sire, Vittorio Aprile, Dario Calafiore, Arianna Folli, Fjorelo Refati, Andrea Balduit, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: Scoping review on rehabilitation strategies in mesothelioma patients.
  • Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
    Published: May 23, 2024, Cancers
    DOI: 10.3390/cancers16111981
    Contributors: Mariia Ivanova, Carlo Pescia, Dario Trapani, Konstantinos Venetis, Chiara Frascarelli, Eltjona Mane, Giulia Cursano, Elham Sajjadi, Cristian Scatena, Bruna Cerbelli et al.
    Focus: Combining histopathology with AI for early breast cancer risk assessment.
  • Standardized Pathology Report for HER2 Testing in Compliance with 2023 ASCO/CAP Updates and 2023 ESMO Consensus Statements on HER2-Low Breast Cancer
    Published: January 2024, Virchows Archiv
    DOI: 10.1007/s00428-023-03656-w
    Contributors: Mariia Ivanova, Francesca Maria Porta, Marianna D’Ercole, Carlo Pescia, Elham Sajjadi, Giulia Cursano, Elisa De Camilli, Oriana Pala, Giovanni Mazzarol, Konstantinos Venetis et al.
    Focus: HER2 testing in breast cancer with updated guidelines.
  • Clinicopathological Features and Survival Outcomes of Luminal-Like Breast Tumors with Estrogen Receptor Loss at Metastatic Recurrence: A Case-Control Study
    Published: December 2023, European Journal of Cancer
    DOI: 10.1016/j.ejca.2023.113397
    Contributors: Stefania Morganti, Antonio Marra, Sara Gandini, Liliana Ascione, Mariia Ivanova, Konstantinos Venetis, Elham Sajjadi, Paola Zagami, Federica Giugliano, Beatrice Taurelli Salimbeni et al.
    Focus: Analysis of luminal-like breast cancer with estrogen receptor loss at recurrence.

Sandhini Agarwal | Medicine | Best Researcher Award

Posted on by Phenomenological Research Awards

Ms. Sandhini Agarwal | Medicine | Best Researcher Award

Medical Student at Valley Vein Health Center, Georgetown University School of Medicine, United States.

🌍Sandhini Agarwal is a medical student at Georgetown University, with extensive experience in clinical settings, research, and leadership. She has worked as a research assistant at UChicago Medicine and Stanford Medicine, focusing on neural network-based systems, pediatric cardiology, and thyroid cancer. Her clinical experience spans pediatrics, ambulatory care, and community health outreach. Additionally, she has held leadership roles in organizations such as Georgetown Street Medicine and the Phoenix Biology RSO at UChicago. She has also been an active volunteer with Street Life Ministries and has received numerous academic awards.

Profile👤

Education 🎓

🎓Sandhini Agarwal attended the University of Chicago, where she earned a B.S. in Biological Sciences and a minor in Health and Society, graduating cum laude with a GPA of 3.88/4.0. During her time at UChicago, she was consistently recognized for her academic excellence, making the Dean’s List from 2021 to 2022 and earning the Clinical Excellence Scholars Track recognition. She also received multiple awards during high school, including the Senior Book Award in Biology and the Faculty Cup Nominee. Sandhini is currently pursuing her medical degree at Georgetown University School of Medicine, Class of 2028. Her academic focus continues to center around biology, medicine, and public health, with a particular interest in addressing health disparities and improving healthcare access for underserved communities. Sandhini’s academic achievements reflect her commitment to excellence and her determination to make a meaningful impact in the medical field.

Experience💼

🩺Sandhini Agarwal has extensive clinical and research experience that spans multiple prestigious institutions. She is currently involved in clinical work at Georgetown Med, including shadowing Dr. Sejal Bavishi in pediatric outpatient clinics and assisting with physical exams. She also plays a key role in community health initiatives through Hoya Clinic and Learn2Derm, where she educates underserved children on skincare. Prior to Georgetown, Sandhini gained valuable experience at UChicago Medicine, conducting patient interviews as a research assistant for the Hospitalist Project. She also worked at Valley Vein Health Center as a patient care coordinator, conducting surveys and researching Ozempic’s impact on lymphedema. In addition to her clinical roles, Sandhini has participated in research at institutions such as Stanford, where she worked on developing neural network-based systems for medical imaging, and at Harvard Medicine, where she researched thyroid cancer pathways. Her experiences in both clinical care and research have provided her with a comprehensive understanding of healthcare.👨‍🔬🌍

Awards and Honors 🏆

Sandhini Agarwal has received several prestigious awards for her academic and extracurricular achievements. At the University of Chicago, she earned a spot on the Dean’s List from 2021 to 2022 and participated in the Clinical Excellence Scholars Track, recognizing her academic prowess and commitment to clinical excellence. In high school, she received multiple honors, including the Senior Book Award in Biology and the Faculty Cup Nominee. Sandhini was also recognized as a National AP Scholar for her high AP scores and received the Katen Metcalf Scholar award in 2021. She was honored with the Aspirations Award by the National Center for Women & Information Technology in 2018 and won several medals in the National Spanish Exam, including Gold in 2017. Sandhini’s accomplishments reflect her strong academic background and her commitment to leadership, service, and excellence in healthcare.

Research Interests 🔬

🔬Sandhini Agarwal’s research focuses on the intersection of biology, medicine, and technology, with a particular interest in pediatric cardiology, endocrinology, and neuroimaging. At UChicago Medicine, she researched FoxF1 expression in the second heart field and its role in cardiomyocyte differentiation and heart development. This work contributed to the understanding of heart disease and its underlying mechanisms. She also worked on analyzing thyroid cancer pathways at Harvard Medicine, focusing on the diagnosis-to-treatment process for thyroid cancer patients. Sandhini’s research experience extends to neural networks for medical imaging at Stanford, where she developed a system to segment brain parenchymal metastatic lesions using radiological data. In addition, she contributed to cardiovascular drug discovery at UChicago, analyzing genomic data and supporting the HeartBioPortal database. Sandhini’s research aims to enhance healthcare delivery and outcomes, with a particular focus on improving diagnostic accuracy, treatment pathways, and patient care, especially in underserved populations.🌿🧪

Conclusion 🔚 

Sandhini Agarwal is highly deserving of the Best Researcher Award. Her dedication to both research and clinical practice, combined with her leadership in social initiatives, demonstrates a holistic approach to the field of medicine. Her achievements indicate a future leader in healthcare and research, and her continued contributions promise even greater impacts in the years to come.

Publications Top Notes 📚

A Holistic Approach to Undesired Content Detection in the Real World

Authors: Markov, T., Zhang, C., Agarwal, S., Jiang, A., Weng, L.

Citations: 35

Year: 2023

Training language models to follow instructions with human feedback

Authors: Ouyang, L., Wu, J., Jiang, X., Leike, J., Lowe, R.

Citations: 3,339

Year: 2022

Learning Transferable Visual Models From Natural Language Supervision

Authors: Radford, A., Kim, J.W., Hallacy, C., Krueger, G., Sutskever, I.

Citations: 9,325

Year: 2021

Language models are few-shot learners

Authors: Brown, T.B., Mann, B., Ryder, N., Sutskever, I., Amodei, D.

Citations: 15,410

Year: 2020

Recursive routing networks: Learning to compose modules for language understanding

Authors: Cases, I., Rosenbaum, C., Riemer, M., Potts, C., Karttunen, L.

Citations: 11

Year: 2019

 

 

Nazanin mahinparvar | Medicine | Best Researcher Award

Posted on by Phenomenological Research Awards

Nazanin mahinparvar | Medicine | Best Researcher Award

Postdoc at Stanford university, United States.

Dr. Nazanin Mahinparvar is a postdoctoral scholar at Stanford University, focusing on bioengineering and pain management. She brings a blend of medical and research expertise to her work, aiming to develop innovative gene therapies that offer non-addictive, effective treatments for chronic pain. Her research in synthetic biology, combined with her clinical background as an emergency medicine physician, underscores her commitment to translating laboratory discoveries into practical healthcare solutions. Throughout her career, she has received numerous accolades for her dedication to patient care and research excellence, including the Best Physician Award during the COVID-19 pandemic. Her approach to research is driven by a patient-centered perspective, making her work both scientifically rigorous and highly relevant to addressing current health challenges. Dr. Mahinparvar’s focus on developing HSV-based biotechnologies has the potential to reshape pain management therapies, positioning her as a significant contributor to advancements in medical science.

Profile👤

Scopus

Education 🎓

Dr. Nazanin Mahinparvar’s educational journey is marked by excellence and a clear dedication to advancing medical knowledge. She began her studies in Biology at SAMPAD in Iran, followed by an MD at Isfahan Medical University, where she was recognized with high honors. Her medical education included an emphasis on pain management, an area she explored further during her mandatory medical service program. Her commitment to lifelong learning and research brought her to Stanford University for a prestigious postdoctoral position in bioengineering. Dr. Mahinparvar’s educational background integrates both foundational medical training and specialized knowledge in synthetic biology and gene therapy. Her academic journey has been marked by a strong interdisciplinary focus, with formal training that spans basic sciences, clinical practice, and cutting-edge bioengineering. This diverse educational foundation provides her with a unique perspective, enabling her to bridge the gap between laboratory research and patient-centered clinical applications.

Experience💼

Dr. Nazanin Mahinparvar has extensive experience in both clinical and research settings, blending hands-on patient care with innovative scientific research. Her early career as a physician involved managing healthcare in underserved areas, where she was honored with the Best Doctor Award for her exceptional patient care. Following this, she served as an emergency medicine physician, honing her ability to operate under pressure. During her postdoctoral work at Stanford, she focused on developing non-toxic HSV-based therapies for chronic pain and neurological disorders. Her clinical experience in pain management, coupled with her research in gene therapy and synthetic biology, has positioned her as a leader in innovative medical research. Dr. Mahinparvar’s experience is a blend of practical and scientific expertise, which she continually refines through collaboration with top scientists and participation in clinical trials. Her background uniquely equips her to drive impactful advancements in pain management and gene-based therapies.

Research Interests 🔬

Dr. Mahinparvar’s research interests focus on engineering advanced, safe, and efficient gene therapies for chronic pain and neurological disorders. She specializes in developing non-addictive pain management treatments using synthetic biology and gene engineering, with a particular interest in non-toxic HSV-based technologies. Dr. Mahinparvar’s work aims to address global health challenges by providing affordable, accessible solutions for conditions that currently lack effective, low-risk treatments. At Stanford’s Wu Tsai Neurosciences Institute, her research delves into combining gene therapy with bioengineering to create precise, targeted interventions. Her early research on selenium’s effects on respiratory functions in ICU patients sparked her interest in translational medicine, which she has expanded to chronic pain and neuro-oncology applications. Dr. Mahinparvar’s research is ultimately driven by her commitment to improving patient outcomes and advancing the field of pain management through innovative, cross-disciplinary approaches that bridge the laboratory and the clinic.

Awards and Honors 🏆

Throughout her career, Dr. Mahinparvar has earned multiple awards recognizing her excellence in both research and clinical practice. In 2021, she received the Best Physician Award for her dedication to patient care during the COVID-19 pandemic, reflecting her commitment to providing quality healthcare under challenging conditions. She was also honored with the Foundation of Future Medical Research Fellowship at the Kheradmand Institute, which brought her to Stanford for advanced research in head and neck surgery and gene therapy. Other accolades include her high-honors MD dissertation award and the Best Student Award from Iran’s SAMPAD organization for exceptional talent. These recognitions highlight Dr. Mahinparvar’s leadership, resilience, and contribution to medicine. Her awards underscore her determination to push the boundaries of traditional pain management, making her a strong candidate for future honors in the fields of bioengineering and clinical research.

Conclusion 🔚 

Dr. Mahinparvar’s academic and clinical achievements, including her innovative work in chronic pain management, place her among the most promising candidates for the Best Researcher Award. Her interdisciplinary research, combined with her commitment to patient care and clinical applications, demonstrates her potential to make lasting contributions to medical science and public health. This award would provide well-deserved recognition and support to advance her impactful research on a global scale.

Publications Top Notes 📚

Title: Oxytocin Receptors on Calvarial Periosteal Innervation: Therapeutic Target for Post-Traumatic Headache?
Authors: Bharadwaj, V.N., Klukinov, M., Cowan, R.P., Mahinparvar, N., Clark, D.J., Yeomans, D.C.
Year: 2024
Journal: Pharmaceutics, 16(6), 760
Citation Count: 0

Title: Chemopreventive and therapeutic potential of curcumin in esophageal cancer: Current and future status
Authors: Hesari, A., Azizian, M., Sheikhi, A., Nesaei, A., Sanaei, S., Mahinparvar, N., Derakhshani, M., Hedayt, P., Ghasemi, F., Mirzaei, H.
Year: 2019
Journal: International Journal of Cancer, 144(6), pp. 1215–1226
Citation Count: 103

Title: Cyclophosphamide versus rituximab in progressive forms of multiple sclerosis
Authors: Etemadifar, M., Ghourchian, S., Mahinparvar, N., Sanaei, S., Akbari, M.
Year: 2019
Journal: Acta Medica Iranica, 57(8), pp. 484–491
Citation Count: 2

Title: Comparison of the efficacy of midazolam and dexmedetomidine in quality of sedation in mechanically-ventilated patients admitted to intensive care unit
Authors: Kashefi, P., Mahinparvar, N., Khalifsoltani-Khajooie, M., Mansouri, P., Sanaei, S.
Year: 2018
Journal: Journal of Isfahan Medical School, 35(460), pp. 1799–1805
Citation Count: 1

Title: The effect of selenium on maximum inspiratory pressure in patients under mechanical ventilation in intensive care units
Authors: Alikiaii, B., Mahinparvar, N.
Year: 2017
Journal: Journal of Isfahan Medical School, 35(423), pp. 291–296
Citation Count: 1